BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5713674)

  • 1. The preparation of a human plasma fraction by cryoprecipitation and its use in haemophilia.
    Waumans P; Van Itterbeek R; Verstraete M
    Acta Clin Belg; 1968; 23(3):139-52. PubMed ID: 5713674
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparation of antihemophilic kryoprecipitates (AHKP) from fresh plasma and its use in hemophilia A].
    Brüster H
    Monatsschr Kinderheilkd (1902); 1968 Jun; 116(6):388-90. PubMed ID: 5718328
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of haemophilia A with purified factor 8 obtained from human plasma by cryoprecipitation.
    Meyer K; Eernisse JG; Veltkamp JJ; Hemker HC; Loeliger EA
    Folia Med Neerl; 1967; 10(2):49-60. PubMed ID: 6039247
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor 8 and antibody levels in plasma fractions prepated by cryoprecipitation.
    Pollock A
    J Clin Pathol; 1968 Sep; 21(5):635-7. PubMed ID: 4972298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasma and plasma fractions as sources of factor VIII (antihaemophilic factor).
    Verstraete M; Olislaegers P; Van Itterbeek H; Waumans P; Lust A
    Vox Sang; 1969 Apr; 16(4):382-97. PubMed ID: 5800592
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cryoprecipitation and dextran precipitation in obtaining factor VIII concentrates: results of redetecting antihemophilic globulin A in a patient].
    Kubel M; Wegner H; Liebe S
    Z Gesamte Inn Med; 1974 Mar; 29(6):236-40. PubMed ID: 4409090
    [No Abstract]   [Full Text] [Related]  

  • 7. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A].
    Kuble M; Wegner H; Cron D
    Z Gesamte Inn Med; 1973 Oct; 28(20):608-14. PubMed ID: 4767194
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of cryoprecipitate concentrate in patients with classical haemophilia.
    Barrett KE; Israëls MC; Burn AM
    Lancet; 1967 Jan; 1(7483):191-2. PubMed ID: 4163324
    [No Abstract]   [Full Text] [Related]  

  • 9. Cryoprecipitate in the management of haemophilia in Kenya.
    Taylor JR; Ahluwalia NS; Morrison CJ; Kaviti JN; Cardwell CL
    East Afr Med J; 1969 Feb; 46(2):121-8. PubMed ID: 5798053
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of haemophilia (factor-8 deficiency) with human antihaemophilic factor prepared by the cryoprecipitate process.
    Prentice CR; Breckenridge RT; Forman WB; Ratnoff OD
    Lancet; 1967 Mar; 1(7488):457-60. PubMed ID: 4164062
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of cryoprecipitate antihaemophilic factor for the treatment of haemophilia.
    Bloom AL; Emmanuel JH
    Q J Med; 1968 Apr; 37(146):291-302. PubMed ID: 5656159
    [No Abstract]   [Full Text] [Related]  

  • 12. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryoprecipitate therapy in haemophilia.
    Forbes CD; Hunter J; Barr RD; Davidson JF; Short DW; McDonald GA; McNicol GP; Wallace J; Douglas AS
    Scott Med J; 1969 Jan; 14(1):1-9. PubMed ID: 5304824
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin and factor VIII.
    Smit Sibinga CT; Das PC
    Scand J Haematol Suppl; 1984; 40():111-22. PubMed ID: 6433440
    [No Abstract]   [Full Text] [Related]  

  • 15. The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial.
    Hershgold EJ; Pool JG; Pappenhagen AR
    J Lab Clin Med; 1966 Jan; 67(1):23-32. PubMed ID: 5321736
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical use of a new glycine-precipitated antihemophilic fraction.
    Webster WP; Roberts HR; Thelin GM; Wagner RH; Brinkhous KM
    Am J Med Sci; 1965 Dec; 250(6):643-51. PubMed ID: 5846510
    [No Abstract]   [Full Text] [Related]  

  • 18. Human factor VIII prepared by cryoprecipitation.
    Masure R
    Vox Sang; 1969 Jan; 16(1):1-9. PubMed ID: 5766099
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preparatory procedures for obtaining antihemolytic globulin (factor VIII) by the cryoprecipitation method and its various properties].
    Lopaciuk S; Naleczyńska A; Klenowska Z; Daszyński J; Pawelski S
    Pol Tyg Lek; 1969 Jun; 24(22):826-9. PubMed ID: 5802316
    [No Abstract]   [Full Text] [Related]  

  • 20. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
    Gaerisch F; Stein P
    Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.